Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: An analysis of 2002-2012 United Network for Organ Sharing data

Clinical Transplantation

Volumn 28, Issue 6, 2014, Pages 713-721

  Wong, Robert J ^a   Chou, Christina ^a   Bonham, Clark A ^a   Concepcion, Waldo ^a   Esquivel, Carlos O ^a   Ahmed, Aijaz ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis C; Hepatocellular carcinoma; Model for end stage liver disease; Non alcoholic steatohepatitis

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BODY MASS; DIABETES MELLITUS; END STAGE LIVER DISEASE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DISEASE; HEPATITIS C; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; GRAFT REJECTION; LIVER DISEASES, ALCOHOLIC; MIDDLE AGED; MORTALITY; NON-ALCOHOLIC FATTY LIVER DISEASE; POSTOPERATIVE COMPLICATION; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS;

FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; NON-ALCOHOLIC FATTY LIVER DISEASE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84901943643     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12364     Document Type: Article

References (33)

1. Hoyert DL, Xu J. Deaths: Preliminary Data for 2011. National Vital Statistics Reports Vol 61 No 6. Hyattsville, MD: National Center for Health Statistics, 2012. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdf
2. Younossi ZM, Stepanova M, Afendy M et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011: 9: 524.
3. Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov, Accessed July 31, 2013.
4. United Network for Organ Sharing (UNOS) Database. www.unos.org. Accessed July 31, 2013.
5. Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013: 95: 755.
6. Wiesner R, Edwards E, Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003: 124: 91.
7. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010: 10: 1003.
8. Ioannou GN, Perkins JD, Carithers RL Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008: 134: 1342.
9. Zalesak M, Francis K, Gedeon A et al. Current and future disease progression of the chronic HCV population in the United States. PLoS ONE 2013: 8: e63959.
10. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009: 49: 1335.
11. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011: 141: 1249.
12. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012: 307: 491.
13. Taniguchi M. Liver transplantation in the MELD era-analysis of the OPTN/UNOS registry. Clin Transpl 2012: 41.
14. Burra P, Freeman R. Trends in liver transplantation 2011. J Hepatol 2012: 56(Suppl 1): S101.
15. Ohe H, Hoshino J, Ozawa M. Factors affecting outcomes of liver transplantation: an analysis of OPTN/UNOS database. Clin Transpl 2011: 39.
16. Ghabril M, Dickson R, Wiesner R. Improving outcomes of liver retransplantation: an analysis of trends and the impact of hepatitis C infection. Am J Transplant 2008: 8: 404.
17. Sawyer RG, Pelletier SJ, Pruett TL. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant 1999: 13: 126.
18. Nair S, Cohen DB, Cohen MP, Tan H, Maley W, Thuluvath PJ. Postoperative morbidity, mortality, cost and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol 2001: 96: 842.
19. Nair A, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002: 35: 105.
20. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004: 10: 886.
21. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009: 9: 782.
22. Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011: 17: 15.
23. Laryea M, Watt KD, Molinari M et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007: 13: 1109.
24. Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg 1998: 4: 285.
25. Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl 2009: 15: 1814.
26. Dumitra S, Alabbad SI, Barkun JS et al. Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience. HPB (Oxford) 2013: 15: 724.
27. Bozorgzadeh A, Orloff M, Abt P et al. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl 2007: 13: 807.
28. Shimoda M, Ghobrial RM, Carmody IC et al. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with hepatitis C. Liver Transpl 2004: 10: 1478.
29. Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Racial and ethnic disparities in access to liver transplantation. Liver Transpl 2010: 16: 1033.
30. Ananthakrishnan AN, Saeian K. Racial differences in liver transplantation outcomes in the MELD era. Am J Gastroenterol 2008: 103: 901.
31. Artinyan A, Mailey B, Sanchez-Luege N et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 2010: 116: 1367.
32. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002: 359: 287.
33. Maggard M, Goss J, Ramdev S, Swenson K, Busuttil RW. Incidence of acute rejection in African-American liver transplant recipients. Transplant Proc 1998: 30: 1492.